TransCode Therapeutics (RNAZ) Short Interest Ratio & Short Volume $3.52 +0.17 (+5.07%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TransCode Therapeutics Short Interest DataTransCode Therapeutics (RNAZ) has a short interest of 89,600 shares, representing 12.89% of the float (the number of shares available for trading by the public). This marks a 70.99% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.5, indicating that it would take 1.5 days of the average trading volume of 105,869 shares to cover all short positions.Current Short Interest89,600 sharesPrevious Short Interest52,400 sharesChange Vs. Previous Month+70.99%Dollar Volume Sold Short$301,952.00Short Interest Ratio1.5 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares700,000 sharesFloat Size695,100 sharesShort Percent of Float12.89%Today's Trading Volume32,826 sharesAverage Trading Volume105,869 sharesToday's Volume Vs. Average31% Short Selling TransCode Therapeutics? Sign up to receive the latest short interest report for TransCode Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRNAZ Short Interest Over TimeRNAZ Days to Cover Over TimeRNAZ Percentage of Float Shorted Over Time TransCode Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/202489,600 shares $301,952.00 +71.0%12.9%1.5 $3.37 12/15/202452,400 shares $388,808.00 +184.8%7.5%0.9 $7.42 11/30/202418,400 shares $6.97 million -91.5%2.7%0.4 $378.97 11/15/2024215,500 shares $73,205.35 -71.0%1.3%0.1 $0.34 10/31/2024743,600 shares $345,774.00 -39.1%4.3%0.4 $0.47 10/15/20241,220,000 shares $901,580.00 -11.6%7.1%0.6 $0.74 9/30/20241,380,000 shares $787,980.00 +52.5%8.0%0.7 $0.57 9/15/2024904,700 shares $234,407.77 +224.7%5.3%0.6 $0.26 8/31/2024278,600 shares $73,383.24 +58.5%1.6%0.2 $0.26 8/15/2024175,800 shares $43,950.00 -89.3%1.0%0.2 $0.25 Get the Latest News and Ratings for RNAZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20241,640,000 shares $459,200.00 +6,539.7%9.6%1.1 $0.28 7/15/202424,700 shares $22,237.41 -85.2%0.4%0 $0.90 6/30/2024167,200 shares $168,036.00 -62.7%2.5%0.1 $1.01 6/15/2024448,500 shares $538,200.00 -56.0%6.9%0.4 $1.20 5/31/20241,020,000 shares $1.81 million +486.5%15.6%0.8 $1.78 5/15/2024173,900 shares $140,267.74 +16.2%2.7%0.1 $0.81 4/30/2024149,600 shares $90,822.16 +704.3%2.3%0.2 $0.61 4/15/202418,600 shares $9,975.18 -53.5%0.3%0 $0.54 3/31/202440,000 shares $27,320.00 -77.1%0.6%0.1 $0.68 3/15/2024174,800 shares $120,786.80 +71.4%2.7%0.3 $0.69 2/29/2024102,000 shares $71,869.20 -53.8%1.6%0.2 $0.70 2/15/2024220,900 shares $145,794.00 -70.8%3.4%0.4 $0.66 1/31/2024755,300 shares $521,912.30 +7,529.3%13.0%1.6 $0.69 1/15/20249,900 shares $49,500.00 -97.6%1.8%0 $5.00 12/31/2023405,000 shares $66,744.00 -7.4%N/A0.1 $0.16 12/15/2023437,500 shares $74,156.25 -31.3%2.0%0.1 $0.17 11/30/2023637,200 shares $156,751.20 +31.8%3.0%0.1 $0.25 11/15/2023483,300 shares $138,610.44 -63.4%2.5%0.1 $0.29 10/31/20231,320,000 shares $488,664.00 +562.0%7.4%0.2 $0.37 10/15/2023199,400 shares $86,100.92 +173.9%6.2%0 $0.43 9/30/202372,800 shares $36,596.56 -42.4%4.5%0 $0.50 9/15/2023126,400 shares $84,511.04 +418.0%7.1%0.1 $0.67 8/31/202324,400 shares $35,380.00 +1,255.6%1.7%0.2 $1.45 8/15/20231,800 shares $2,916.00 -87.8%0.1%0 $1.62 7/31/202314,700 shares $32,340.00 -85.5%2.5%0.1 $2.20 7/15/2023101,500 shares $257,810.00 +81.9%16.9%0.4 $2.54 6/30/202355,800 shares $128,340.00 +14.6%9.3%0.2 $2.30 6/15/202348,700 shares $129,055.00 +79.7%8.1%0.2 $2.65 5/31/202327,100 shares $113,820.00 +22.1%4.4%0.2 $4.20 5/15/202322,200 shares $135,109.20 -96.6%N/A0.5 $6.09Did You See Trump’s Manhattan Project Bombshell? (Ad)This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years. Click here and see for yourself. 4/30/2023653,200 shares $206,345.88 +2.7%5.6%0.4 $0.32 4/15/2023636,000 shares $250,965.60 +99.5%5.5%0.4 $0.39 3/31/2023318,800 shares $107,913.80 +21.0%2.8%0.2 $0.34 3/15/2023263,500 shares $91,618.95 -51.3%2.3%0.2 $0.35 2/28/2023541,400 shares $282,069.40 -42.9%4.7%0.1 $0.52 2/15/2023948,400 shares $635,428.00 +104.5%7.5%0.2 $0.67 1/31/2023463,700 shares $348,145.96 +0.8%5.3%0.2 $0.75 1/15/2023459,900 shares $281,458.80 -43.5%5.3%0.1 $0.61 12/30/2022814,100 shares $547,889.30 -22.5%9.4%0.3 $0.67 12/15/20221,050,000 shares $472,290.00 +2,849.4%12.1%0.4 $0.45 11/30/202235,600 shares $14,240.00 +368.4%0.4%0 $0.40 11/15/20227,600 shares $4,164.80 -96.5%0.1%0 $0.55 10/31/2022218,800 shares $147,033.60 +478.8%2.5%0.3 $0.67 10/15/202237,800 shares $41,995.80 -2.1%0.4%1.9 $1.11 9/30/202238,600 shares $42,460.00 +565.5%0.4%1.9 $1.10 9/15/20225,800 shares $6,728.00 -29.3%0.1%0.3 $1.16 8/31/20228,200 shares $9,840.00 +90.7%0.1%0.2 $1.20 8/15/20224,300 shares $5,547.00 -66.4%0.1%0.1 $1.29 7/31/202212,800 shares $18,176.00 +1.6%0.2%0.3 $1.42 7/15/202212,600 shares $16,632.00 +26.0%0.1%0.3 $1.32 6/30/202210,000 shares $12,600.00 +1.0%0.1%0.2 $1.26 6/15/20229,900 shares $12,573.00 -52.9%0.1%0.3 $1.27 5/31/202221,000 shares $38,640.00 -15.7%0.2%1.1 $1.84 5/15/202224,900 shares $56,025.00 -46.6%0.3%1.5 $2.25 4/30/202246,600 shares $127,218.00 +88.7%0.5%2.9 $2.73 4/15/202224,700 shares $70,814.90 -44.9%0.3%1.4 $2.87 3/31/202244,800 shares $129,024.00 +37.9%0.5%2 $2.88 3/15/202232,500 shares $70,200.00 -38.2%0.4%0.9 $2.16 2/28/202252,600 shares $112,038.00 -37.8%0.7%1.3 $2.13 2/15/202284,600 shares $181,044.00 -12.6%1.2%1.6 $2.14 1/31/202296,800 shares $222,640.00 -24.7%1.4%1.6 $2.30 1/15/2022128,500 shares $322,535.00 +51.4%1.8%1.6 $2.51 12/31/202184,900 shares $215,646.00 +0.7%1.2%0.7 $2.54 12/15/202184,300 shares $207,378.00 +157.0%1.2%0.3 $2.46 11/30/202132,800 shares $90,200.00 +32.8%0.5%0 $2.75 11/15/202124,700 shares $73,606.00 -86.7%0.4%0 $2.98 10/29/2021185,900 shares $526,097.00 -22.9%2.6%0 $2.83 10/15/2021241,100 shares $776,342.00 -47.1%3.4%0.1 $3.22 9/30/2021455,400 shares $1.36 million +1,350.3%6.4%0.1 $2.99 9/15/202131,400 shares $81,012.00 -39.7%0.4%0 $2.58 8/31/202152,100 shares $158,384.00 +128.5%0.7%0 $3.04 8/13/202122,800 shares $65,436.00 No Change0.4%0 $2.87 RNAZ Short Interest - Frequently Asked Questions What is TransCode Therapeutics' current short interest? Short interest is the volume of TransCode Therapeutics shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 89,600 shares of RNAZ short. 12.89% of TransCode Therapeutics' shares are currently sold short. Learn More on TransCode Therapeutics' current short interest. What is a good short interest ratio for TransCode Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RNAZ shares currently have a short interest ratio of 2.0. Learn More on TransCode Therapeutics's short interest ratio. What is a good short interest percentage for TransCode Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.89% of TransCode Therapeutics' floating shares are currently sold short. Is TransCode Therapeutics' short interest increasing or decreasing? TransCode Therapeutics saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 89,600 shares, an increase of 71.0% from the previous total of 52,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TransCode Therapeutics' float size? TransCode Therapeutics currently has issued a total of 700,000 shares. Some of TransCode Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TransCode Therapeutics currently has a public float of 695,100 shares. How does TransCode Therapeutics' short interest compare to its competitors? 12.89% of TransCode Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to TransCode Therapeutics: SciSparc Ltd. (7.68%), Biofrontera Inc. (4.71%), Cyclerion Therapeutics, Inc. (4.33%), Eagle Pharmaceuticals, Inc. (2.90%), Ainos, Inc. (4.22%), Addex Therapeutics Ltd (0.70%), NLS Pharmaceutics Ltd. (21.37%), Soligenix, Inc. (0.58%), Orgenesis Inc. (0.29%), Virax Biolabs Group Limited (4.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short TransCode Therapeutics stock? Short selling RNAZ is an investing strategy that aims to generate trading profit from TransCode Therapeutics as its price is falling. RNAZ shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TransCode Therapeutics? A short squeeze for TransCode Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RNAZ, which in turn drives the price of the stock up even further. How often is TransCode Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNAZ, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies SciSparc Short Interest Data Biofrontera Short Interest Data Cyclerion Therapeutics Short Interest Data Eagle Pharmaceuticals Short Interest Data Ainos Short Interest Data Addex Therapeutics Short Interest Data NLS Pharmaceutics Short Interest Data Soligenix Short Interest Data Orgenesis Short Interest Data Virax Biolabs Group Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RNAZ) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNAZ Stock Alerts